Biostimulator
Pronunciation: by-oh-STY-myoo-lay-tor
An injectable agent that stimulates the body's own fibroblasts to produce new collagen and elastin rather than directly providing volumetric fill.
Full Definition
Biostimuators—most commonly poly-L-lactic acid (Sculptra) and calcium hydroxylapatite (Radiesse)—work through a delayed mechanism: the injected particles provoke a controlled fibroblastic response that gradually increases dermal collagen density over weeks to months. Unlike conventional hyaluronic acid fillers, which provide immediate volumetric correction, biostimuators yield results that develop progressively and require a series of treatment sessions. Editorial confusion often arises because biostimuators are sometimes marketed under the umbrella term 'dermal filler', which is technically imprecise. The term is written as a single unhyphenated word; 'bio-stimulator' is a non-standard variant. Editors working on regulatory or consent documentation should ensure the mechanism of action is accurately described, as the distinction has medico-legal implications.
Usage
Usage note: Write as one word without a hyphen. Do not use 'dermal filler' as a synonym in clinical or regulatory texts; the distinction is medico-legally significant.
In Context
- "The consent form incorrectly listed Sculptra as a 'filler'; the editor amended this to 'biostimulator' to accurately reflect its mechanism." — Patient consent form
- "In the product monograph, 'biostimulator' and 'dermal filler' must be treated as distinct categories with separate regulatory pathways." — Regulatory product monograph